| 0 |
TRACHEAL INFLAMMATION |
1 |
0.0092 |
| 1 |
PYOTHORAX |
1 |
0.0079 |
| 2 |
LATEX ALLERGY |
1 |
0.0041 |
| 3 |
PRODUCT BARCODE ISSUE |
1 |
0.0026 |
| 4 |
RESPIRATORY TRACT OEDEMA |
1 |
0.0013 |
| 5 |
CREATINE KINASE INCREASED |
1 |
0.0013 |
| 6 |
JOINT CONTRACTURE |
1 |
0.0009 |
| 7 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
3 |
0.0006 |
| 8 |
SKIN INDURATION |
1 |
0.0005 |
| 9 |
EYELID IRRITATION |
1 |
0.0004 |
| 10 |
TORSADE DE POINTES |
3 |
0.0004 |
| 11 |
SKIN WRINKLING |
1 |
0.0004 |
| 12 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 13 |
NEGATIVE THOUGHTS |
1 |
0.0003 |
| 14 |
NEPHROGENIC SYSTEMIC FIBROSIS |
1 |
0.0003 |
| 15 |
DYSCHEZIA |
1 |
0.0003 |
| 16 |
RECURRENT CANCER |
1 |
0.0002 |
| 17 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 18 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 19 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 20 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 21 |
VENTRICULAR TACHYCARDIA |
3 |
0.0002 |
| 22 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 23 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 24 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 25 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 26 |
LUNG INFILTRATION |
1 |
0.0001 |
| 27 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 28 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 29 |
ASPIRATION |
1 |
0.0001 |
| 30 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 31 |
RESTLESSNESS |
3 |
0.0001 |
| 32 |
CARDIOMEGALY |
1 |
0.0001 |
| 33 |
PANCREATITIS |
4 |
0.0001 |
| 34 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 35 |
OXYGEN SATURATION DECREASED |
4 |
0.0001 |
| 36 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 37 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 38 |
CHOLELITHIASIS |
2 |
0.0001 |
| 39 |
COAGULOPATHY |
1 |
0.0001 |
| 40 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 41 |
HERNIA |
1 |
0.0001 |
| 42 |
RETCHING |
1 |
0.0000 |
| 43 |
MELAENA |
1 |
0.0000 |
| 44 |
TOOTH DISORDER |
1 |
0.0000 |
| 45 |
ORAL PAIN |
1 |
0.0000 |
| 46 |
ABASIA |
1 |
0.0000 |
| 47 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 48 |
AGEUSIA |
1 |
0.0000 |
| 49 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 50 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 51 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 52 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 53 |
LIP SWELLING |
1 |
0.0000 |
| 54 |
NIGHTMARE |
1 |
0.0000 |
| 55 |
HYPOXIA |
1 |
0.0000 |
| 56 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 57 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 58 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 59 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 60 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 61 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 62 |
HYPOACUSIS |
1 |
0.0000 |
| 63 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 64 |
AGGRESSION |
1 |
0.0000 |
| 65 |
FLUID RETENTION |
1 |
0.0000 |
| 66 |
THERAPY CESSATION |
1 |
0.0000 |
| 67 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 68 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 69 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 70 |
BLISTER |
1 |
0.0000 |
| 71 |
LETHARGY |
1 |
0.0000 |
| 72 |
WHEEZING |
1 |
0.0000 |
| 73 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 74 |
VERTIGO |
1 |
0.0000 |
| 75 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 76 |
SWELLING FACE |
1 |
0.0000 |
| 77 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 78 |
BURNING SENSATION |
1 |
0.0000 |
| 79 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 80 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 81 |
BRONCHITIS |
1 |
0.0000 |
| 82 |
EPISTAXIS |
1 |
0.0000 |
| 83 |
DRY MOUTH |
1 |
0.0000 |
| 84 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 85 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 86 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 87 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 88 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 89 |
DYSPHAGIA |
1 |
0.0000 |
| 90 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 91 |
HEART RATE INCREASED |
1 |
0.0000 |
| 92 |
HYPOTENSION |
2 |
0.0000 |
| 93 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 94 |
HAEMORRHAGE |
1 |
0.0000 |
| 95 |
WEIGHT INCREASED |
2 |
0.0000 |
| 96 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 97 |
DECREASED APPETITE |
2 |
0.0000 |
| 98 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 99 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 100 |
DEHYDRATION |
1 |
0.0000 |
| 101 |
DRY SKIN |
1 |
0.0000 |
| 102 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 103 |
VISION BLURRED |
1 |
0.0000 |
| 104 |
WEIGHT DECREASED |
2 |
0.0000 |
| 105 |
COUGH |
2 |
0.0000 |
| 106 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 107 |
VOMITING |
3 |
0.0000 |
| 108 |
PNEUMONIA |
2 |
0.0000 |
| 109 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 110 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 111 |
CHEST PAIN |
1 |
0.0000 |
| 112 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 113 |
CONSTIPATION |
1 |
0.0000 |
| 114 |
MALAISE |
2 |
0.0000 |
| 115 |
NAUSEA |
3 |
0.0000 |
| 116 |
DYSPNOEA |
2 |
0.0000 |
| 117 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 118 |
DIARRHOEA |
2 |
0.0000 |
| 119 |
ASTHENIA |
1 |
0.0000 |
| 120 |
PRURITUS |
1 |
0.0000 |
| 121 |
DIZZINESS |
1 |
0.0000 |
| 122 |
PAIN |
1 |
0.0000 |
| 123 |
DEATH |
1 |
0.0000 |
| 124 |
OFF LABEL USE |
1 |
0.0000 |
| 125 |
DRUG INEFFECTIVE |
1 |
0.0000 |